Clinical Trial Update: Study to Evaluate the Efficacy and Safety of RPH-104 Treatment in Patients With Idiopathic Recurrent Pericarditis [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for RPH-104 evaluating efficacy and safety in idiopathic recurrent pericarditis has completed Phase 2 and Phase 3. No detailed results a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Recurrent Pericarditis
• Pericarditis

Drugs mentioned

• RPH-104

Snippet

Sponsor: R-Pharm International, LLC | Conditions: Pericarditis | Phase 2, Phase 3 | Status: COMPLETED